Phase II Study of Pembrolizumab Plus GVD As Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma
Year: 2020
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Alison J. Moskowitz, Gunjan Shah, Heiko Schöder, Nivetha Ganesan, Helen Hancock, Theresa Davey, Samia Sohail, Alayna Santarosa, Lauren Pomerantz, Christine Jarjies, Natasha Galasso, Rachel Neuman, Anita Kumar, Oscar B Lahoud, Connie Lee Batlevi, Paul A. Hamlin, David J. Straus, Ildefonso Rodriguez-Rivera, Colette Owens, Philip Caron, Andrew M. Intlekofer, Audrey Hamilton, Steven M. Horwitz, Lorenzo Falchi, Erel Joffe, Maria Lia Palomba, Ariela Noy, Matthew J Matasar, Georgios Pongas, Santosha Vardhana, Gottfried R. von Keudell, Joachim Yahalom, Andrew D Zelenetz, Craig H. Moskowitz
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3095998607